CDMO Activity Tracker: Bora, PolPharma make acquisitions; Evonik, EUROAPI, Porton announce technological expansions

Data Compilation
#PharmaFlow

Pipeline Prospector Nov 2024: Trump’s HHS pick drags down jab makers’ stocks; Novartis, Merck, Roche ink billion-dollar deals

Stock Recap
#PipelineProspector

IMIPRAMINE PAMOATE

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

12 API Suppliers, 9 USDMF, 2 EU WC, 1 NDC API, 2 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

3 Intermediates Suppliers

3 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

26 FDF Dossiers, 16 FDA Orange Book, 2 Europe, 3 Australia, 2 South Africa, 3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 125MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 150MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 75MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 SPI Pharma, 8 DKSH, 3 Faran Shimi Pharmaceutical, 7 Gangwal Healthcare, 4 ACG Worldwide, 1 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 BASF, 1 DFE Pharma, 3 Gangwal Chemicals, 3 Ingredion Pharma Solutions, 1 Kerry, 3 Lonza Capsugel, 5 Microlex e.U, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 1 Qualicaps, 10 Roquette, 1 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Sigachi Industries, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

25 Fillers, Diluents & Binders, 15 Lubricants & Glidants, 13 Disintegrants & Superdisintegrants, 12 Direct Compression, 9 Coating Systems & Additives, 9 Thickeners and Stabilizers, 8 Empty Capsules, 6 Co-Processed Excipients, 6 Taste Masking, 5 Granulation, 4 Controlled & Modified Release, 3 Chewable & Orodispersible Aids, 3 Coloring Agents, 3 Emulsifying Agents, 3 Film Formers & Plasticizers, 1 Surfactant & Foaming Agents, 1 API Stability Enhancers, 1 Topical

DIGITAL CONTENT

6 NEWS #PharmaBuzz

6 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 2 Finished Drug Prices

MARKET PLACE

2 APIs

2 APIs

REF. STANDARDS & IMPURITIES

1 USP, 1 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/11/2024	Corden Pharma Bergamo S.p.A	Italy	FARCHEMIA SRL	23076	IMIPRAMINE PAMOATE	2009-08-26	Inactive	II	N/A
28/11/2024	H. Lundbeck AS	Denmark	LUNDBECK PHARMACEUTICALS ITALY SPA	22104	IMIPRAMINE PAMOATE	2008-10-15	Active	II	N/A

IMIPRAMINE PAMOATE

IMIPRAMINE PAMOATE

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

12 API Suppliers

9 USDMF

2 EU WC

1 NDC API

2 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

INTERMEDIATES

3 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

26 FDF Dossiers

16 FDA Orange Book

2 Europe

3 Australia

2 South Africa

3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 125MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 150MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 75MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 SPI Pharma

8 DKSH

3 Faran Shimi Pharmaceutical

7 Gangwal Healthcare

4 ACG Worldwide

1 Aeon Procare

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

5 BASF

1 DFE Pharma

3 Gangwal Chemicals

3 Ingredion Pharma Solutions

1 Kerry

3 Lonza Capsugel

5 Microlex e.U

1 Pharmatrans-Sanaq

3 Pluviaendo

2 Prachin Chemical

1 Qualicaps

10 Roquette

1 Seppic

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

3 Sigachi Industries

2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

25 Fillers, Diluents & Binders

15 Lubricants & Glidants

13 Disintegrants & Superdisintegrants

12 Direct Compression

9 Coating Systems & Additives

9 Thickeners and Stabilizers

8 Empty Capsules

6 Co-Processed Excipients

6 Taste Masking

5 Granulation

4 Controlled & Modified Release

3 Chewable & Orodispersible Aids

3 Coloring Agents

3 Emulsifying Agents

3 Film Formers & Plasticizers

1 Surfactant & Foaming Agents

1 API Stability Enhancers

1 Topical

DIGITAL CONTENT

6 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

2 Finished Drug Prices

MARKET PLACE

2 APIs

REF. STANDARDS & IMPURITIES

CAPSULE;ORAL - EQ 100MG HYDROCHLORIDE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 125MG HYDROCHLORIDE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 150MG HYDROCHLORIDE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 75MG HYDROCHLORIDE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons